IVBXF Stock, Innovent Biologics Inc Information

Innovent is a China-based biotechnology company that is developing drugs for a wide array of diseases, especially oncology therapeutics. Founded in 2011, it listed on the Hong Kong Stock Exchange in 2018. Its core asset is Tyvyt, a PD-1 inhibitor. It also has a portfolio of biosimilars and other fast follower drugs. Innovent has been adept global business development, having out-licensed Tyvyt to Eli Lilly and in-licensed innovative drugs from several partners.